Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daobin Zhou, PhD
Peking Union Medical College Hospital
Principal Investigator - Huiqiang Huang, PhD
Sun Yat-Sen University Cancer Center
Study Director - Jifeng Feng, PhD
Jiangsu Cancer Institute & Hospital
Principal Investigator - Jun Zhu, PhD
Peking University Cancer Hospital & Institute
Principal Investigator - Lugui Qiu, PhD
Tianjin Hematonosis Hospital
Principal Investigator - Ping Zou, PhD
Union Hospital of Tongji Medical College of Huazhong University of Science ＆ Technology
Principal Investigator - Qitao Yu, PhD
Cancer Hospital of Guangxi Medical University
Principal Investigator - Ting Liu, PhD
West China Hospital
Principal Investigator - Weijing Zhang, PhD
Affiliated Hospital of Chinese PLA Military Academy of Medical Sciences
Principal Investigator - Wenbin Qian, PhD
First Affiliated Hospital of Zhejiang University
Principal Investigator - Yiping Zhang, PhD
Zhejiang Cancer Hospital
Principal Investigator - Yu Yang, PhD
Fujian Cancer Hospital
Principal Investigator - Yuankai Shi, PhD
Cancer Institute ＆Hospital. China Academy of Medical Sciences
Principal Investigator - Zhongzhen Guan, PhD
Sun Yat-Sen University Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sun-Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- 31 Dec 2010
- Completion
- 28 Feb 2011
- Last update posted
- 26 Oct 2011
- Registered enrollment
- 278
- Registry id
- NCT01459887
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.